Ethical Stem Cell Research Tax Credit Act of 2008
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Ethical Stem Cell Research Tax Credit Act of 2008 - Amends the Internal Revenue Code to allow a tax credit for 30% of qualified stem cell research expenses paid or incurred in a taxable year. Defines "qualified stem cell research expenses" as expenses for carrying out basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of or treatments for diseases and other adverse health conditions. Prohibits a tax credit for any research expenses that may involve: (1) the creation of a human embryo for research purposes; (2) the destruction of or discarding of, or risk of injury to, a human embryo; or (3) the use of any stem cell for prohibited purposes.
Read twice and referred to the Committee on Finance.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2863: Ethical Stem Cell Research Tax Credit Act of 2008. 110th Congress. Open America. https://openamerica.io/bill/110-S-2863/
"S. 2863: Ethical Stem Cell Research Tax Credit Act of 2008." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-S-2863/.
S. 2863, 110th Cong. (2026), https://openamerica.io/bill/110-S-2863/.
[S. 2863: Ethical Stem Cell Research Tax Credit Act of 2008](https://openamerica.io/bill/110-S-2863/)